150 related articles for article (PubMed ID: 33857297)
1. Discovering novel cancer bio-markers in acquired lapatinib resistance using Bayesian methods.
Azad AKM; Alyami SA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33857297
[TBL] [Abstract][Full Text] [Related]
2. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
[TBL] [Abstract][Full Text] [Related]
3. Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling.
Azad AK; Lawen A; Keith JM
BMC Syst Biol; 2015 Jan; 9():2. PubMed ID: 25599599
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
[TBL] [Abstract][Full Text] [Related]
5. Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer.
Azad AK; Lawen A; Keith JM
PLoS One; 2017; 12(3):e0173331. PubMed ID: 28288164
[TBL] [Abstract][Full Text] [Related]
6. Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines.
O'Neill F; Madden SF; Aherne ST; Clynes M; Crown J; Doolan P; O'Connor R
Mol Cancer; 2012 Jun; 11():41. PubMed ID: 22709873
[TBL] [Abstract][Full Text] [Related]
7. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
Eustace AJ; Conlon NT; McDermott MSJ; Browne BC; O'Leary P; Holmes FA; Espina V; Liotta LA; O'Shaughnessy J; Gallagher C; O'Driscoll L; Rani S; Madden SF; O'Brien NA; Ginther C; Slamon D; Walsh N; Gallagher WM; Zagozdzon R; Watson WR; O'Donovan N; Crown J
BMC Cancer; 2018 Oct; 18(1):965. PubMed ID: 30305055
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Choi JD; Kwon K; Jang CS; Ro YT; Noh YH; Kim SY
Tumour Biol; 2016 Feb; 37(2):2285-97. PubMed ID: 26361955
[TBL] [Abstract][Full Text] [Related]
9. Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.
Havaleshko DM; Smith SC; Cho H; Cheon S; Owens CR; Lee JK; Liotta LA; Espina V; Wulfkuhle JD; Petricoin EF; Theodorescu D
Neoplasia; 2009 Nov; 11(11):1185-93. PubMed ID: 19881954
[TBL] [Abstract][Full Text] [Related]
10. Bayesian Network to Infer Drug-Induced Apoptosis Circuits from Connectivity Map Data.
Yu J; Silva JM
Methods Mol Biol; 2018; 1783():361-378. PubMed ID: 29767372
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
12. Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer.
Liu J; Chen X; Ward T; Mao Y; Bockhorn J; Liu X; Wang G; Pegram M; Shen K
Int J Biochem Cell Biol; 2016 Feb; 71():12-23. PubMed ID: 26643609
[TBL] [Abstract][Full Text] [Related]
13. A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer.
Nam S; Chang HR; Jung HR; Gim Y; Kim NY; Grailhe R; Seo HR; Park HS; Balch C; Lee J; Park I; Jung SY; Jeong KC; Powis G; Liang H; Lee ES; Ro J; Kim YH
Cancer Lett; 2015 Jan; 356(2 Pt B):880-90. PubMed ID: 25449779
[TBL] [Abstract][Full Text] [Related]
14. Enhanced PI3K p110α signaling confers acquired lapatinib resistance that can be effectively reversed by a p110α-selective PI3K inhibitor.
Brady SW; Zhang J; Seok D; Wang H; Yu D
Mol Cancer Ther; 2014 Jan; 13(1):60-70. PubMed ID: 24249715
[TBL] [Abstract][Full Text] [Related]
15. An Integrated Systems Biology and Network-Based Approaches to Identify Novel Biomarkers in Breast Cancer Cell Lines Using Gene Expression Data.
Khan A; Rehman Z; Hashmi HF; Khan AA; Junaid M; Sayaf AM; Ali SS; Hassan FU; Heng W; Wei DQ
Interdiscip Sci; 2020 Jun; 12(2):155-168. PubMed ID: 32056139
[TBL] [Abstract][Full Text] [Related]
16. Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Corominas-Faja B; Urruticoechea A; Martin-Castillo B; Menendez JA
Oncotarget; 2012 Dec; 3(12):1600-14. PubMed ID: 23307622
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells.
Lanceta L; O'Neill C; Lypova N; Li X; Rouchka E; Waigel S; Gomez-Gutierrez JG; Chesney J; Imbert-Fernandez Y
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344635
[TBL] [Abstract][Full Text] [Related]
18. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
Bild AH; Parker JS; Gustafson AM; Acharya CR; Hoadley KA; Anders C; Marcom PK; Carey LA; Potti A; Nevins JR; Perou CM
Breast Cancer Res; 2009; 11(4):R55. PubMed ID: 19638211
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
20. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
